23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia
Overview
The 23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia is a direct-to-consumer genetic test designed to report on an individual’s genetic predisposition to developing harmful blood clots. Specifically, it screens for the Factor V Leiden variant in the F5 gene and the Prothrombin G20210A variant in the F2 gene, which are the two most common variants linked to hereditary thrombophilia.
This test is intended for individuals 18 years and older and is most relevant for people of European descent, though these variants are also found in populations with European ancestry, such as African Americans and Hispanics or Latinos. It provides risk estimates for developing a harmful blood clot for the first time but does not diagnose hereditary thrombophilia or any other health conditions. Users are advised to consult with a healthcare professional to discuss their results and overall risk, as lifestyle, environment, and other factors also contribute to the risk of blood clots.
The test is part of 23andMe’s broader Health + Ancestry Service, which offers a range of genetic health risk, carrier status, and wellness reports. Customers provide a saliva sample, which is then analyzed using single nucleotide polymorphism (SNP) genotyping. Results are delivered through a secure online account and can be accessed via a mobile app.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Detection of Factor V Leiden variant (F5 gene)
- Detection of Prothrombin G20210A variant (F2 gene)
- Direct-to-consumer saliva sample collection
- Personalized online genetic health risk reports
- Access to ancestry reports and DNA relative finder
- Educational resources for healthcare professionals
- Optional participation in genetic research
Use Cases
- Understanding genetic predisposition to harmful blood clots
- Informing discussions with healthcare professionals about personal health risks
- Assessing genetic risk factors for family planning
- Proactive health management and lifestyle considerations
- Contributing to scientific and medical research
What Physicians Need to Know
Physicians should understand that the 23andMe Hereditary Thrombophilia report identifies genetic predispositions based on two common variants (Factor V Leiden and Prothrombin G20210A) and is not a diagnostic test. Results should be interpreted in the context of a patient's full medical history, family history, and other risk factors. The test is most relevant for individuals of European descent. Genetic counseling is recommended for patients with positive results to discuss implications, further testing, and management strategies. The report can serve as a starting point for discussions about personalized care and preventative measures.
The 23andMe Personal Genome Service is a direct-to-consumer product. It does not directly integrate with electronic health records (EHR) systems or other clinical decision support platforms. Patients receive their results through a secure online account, which they can then share with their healthcare providers. 23andMe provides resources and information for clinicians to help them understand and interpret patient results.
Details
| Category | Clinical Decision Support & Reference, Lab & Diagnostics |
| Pricing | $99 - $499+ |
| Deployment | Cloud |
| Mobile App | 1 |
| Compliance | |
| BAA Available | No AI-estimated |
| HIPAA Compliant | No AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Hematology, Laboratory Medicine |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2017-04-06 | DEN160026 De Novo | 23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate 23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia
Videos
Product demos, reviews, and walkthroughs for 23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia.
No videos found. Search YouTube directly
Frequently Asked Questions
Compare 23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia
VS
VS
VS
VS
Investors who backed 23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia
Funded through the company that built this tool.







